optiQGain

About:

optiQGain is a innovative molecular level diagnostic company with imaging systems based on Quantum-Optics techniques.

Website: http://www.optiqgain.com

Top Investors: EASME - EU Executive Agency for SMEs, South Israel Bridging Fund

Description:

optiQGain is developing innovative molecular level diagnostic & imaging systems based on Quantum-Optics techniques. optiQGain introduces an affordable, real-time, lightweight & on-site system for high resolution molecular level analysis. Pioneer an innovative, Stimulated Raman Scattering (SRS) spectrophotometer which enables label-free detection of target molecules less than 1 sec. Applications in medicine, energy, PAT, food storage and more. optiQGain accelerates the medical diagnostic revolution - by taking high-resolution molecular level detection from lab to bed-side & homecare. optiQGain proposes a dramatic change in the “modus operandi” of clinical medicine: real-time, on-line bedside monitoring that enables pre/early symptoms detection, and continuous follow-up treatment effects - thus reducing morbidity, mortality and cost.

Total Funding Amount:

$559000

Headquarters Location:

Ashqelon, HaDarom, Israel

Founded Date:

2011-01-01

Contact Email:

ram.alon(AT)optiqgain.com

Founders:

Ram Alon

Number of Employees:

1-10

Last Funding Date:

2021-05-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai